[EN] NOVEL TETRAHYDROPYRAZOLOPYRIDINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES<br/>[FR] NOUVEAUX COMPOSÉS DE TETRAHYDROPYRAZOLOPYRIDINE POUR LE TRAITEMENT DES MALADIES INFECTIEUSES
申请人:HOFFMANN LA ROCHE
公开号:WO2018011100A1
公开(公告)日:2018-01-18
The present invention relates to compounds of the formula (I), or pharmaceutically acceptable salts, enantiomer or diastereomer thereof, wherein R1 to R5 are as described above. The compounds may be useful for the treatment or prophylaxis of hepatitis B virus infection.
本发明涉及式(I)的化合物,或其药用可接受的盐、对映体或非对映体,其中R1到R5如上所述。这些化合物可能对治疗或预防乙型肝炎病毒感染有用。